Sign In
Buy DYAI
$1.05
-0.0200 (-1.87%)
At Close: Jul 31, 2026
Dyadic International, Inc. (DYAI) Q4 2022 Earnings Call Transcript
08:42pm, Wednesday, 29'th Mar 2023
Dyadic International, Inc. (NASDAQ:DYAI ) Q4 2022 Results Conference Call March 29, 2023 5:00 PM ET Company Participants Ping Rawson - Chief Financial Officer Mark Emalfarb - President and Chief Execu
Dyadic to Report 2022 Year End Financial Results on Wednesday, March 29, 2023
08:30am, Wednesday, 15'th Mar 2023
JUPITER, Fla., March 15, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused
Dyadic to Present at Roth Investor Conference and Upcoming Industry Events
08:30am, Wednesday, 01'st Mar 2023
JUPITER, Fla., March 01, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbia
Dyadic to Participate in Two Upcoming Investor Conferences
08:30am, Thursday, 02'nd Feb 2023
JUPITER, Fla., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial
Dyadic to Attend J.P. Morgan 41st Annual Healthcare Conference
01:30pm, Wednesday, 04'th Jan 2023 GlobeNewswire Inc.
Dyadic's executive management to attend the J.P. Morgan 41st Annual Healthcare Conference and the 6th Annual BFC Global Healthcare BD and Investment Conference from January 8-12 in San Francisco, CA
Dyadic's DYAI-100 COVID-19 Vaccine Study Published in a Leading Peer-Reviewed Scientific Journal
01:30pm, Wednesday, 14'th Dec 2022 GlobeNewswire Inc.
“Thermophilic Filamentous Fungus C1-Cell-Cloned SARS-CoV-2-Spike-RBD-Subunit-Vaccine Adjuvanted with Aldydrogel®85 Protects K18-hACE2 Mice against Lethal Virus Challenge”
Dyadic International, Inc. (DYAI) Q3 2022 Earnings Call Transcript
09:14pm, Thursday, 10'th Nov 2022
Dyadic International, Inc. (NASDAQ:DYAI ) Q3 2022 Earnings Conference Call November 10, 2022 5:00 PM ET Company Participants Ping Rawson – Chief Financial Officer Mark Emalfarb – President and Chi
Dyadic to Present at Upcoming Industry and Investor Events in November
08:30am, Monday, 07'th Nov 2022
JUPITER, Fla., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial
Dyadic to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022
08:30pm, Thursday, 27'th Oct 2022 GlobeNewswire Inc.
JUPITER, Fla., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused
Dyadic to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022
04:30pm, Thursday, 27'th Oct 2022
JUPITER, Fla., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused o
Dyadic Receives Regulatory Approval to Initiate Phase 1 Clinical Trial to Demonstrate Clinical Safety and Efficacy in Humans for DYAI-100 COVID-19 Recombinant Protein RBD Booster Vaccine Candidate
01:04pm, Thursday, 27'th Oct 2022 GlobeNewswire Inc.
JUPITER, Fla., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused
Dyadic to Present Disruptive C1 Technology at World Vaccine Congress Europe Announcing Expansion of Influenza Pipeline with Enhanced Efficacy Potential
12:45pm, Tuesday, 04'th Oct 2022 GlobeNewswire Inc.
JUPITER, Fla., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbi
JUPITER, Fla., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial
Dyadic Updates Market on Recent Scientific Achievements
12:00pm, Tuesday, 13'th Sep 2022 GlobeNewswire Inc.
JUPITER, Fla., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microb
Dyadic to Present at Upcoming Industry and Investor Events in September
12:30pm, Thursday, 08'th Sep 2022 GlobeNewswire Inc.
JUPITER, Fla., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microb
